A Study Evaluating the Safety and Pharmacology of Atezolizumab Administered in Combination With Immunomodulatory Agents in Participants With Acute Myeloid Leukemia (AML)
Clinical trial NCT02892318 · COMPLETED
Trial details
- NCT number
- NCT02892318
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-31
- Primary completion
- 2019-12-12
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.